Fulgent Genetics share price today

(FLGT)

Fulgent Genetics share price is $18.34 & ₹1,558.46 as on 21 Dec 2024, 2.30 'hrs' IST

$18.34

▲

-0.41

(-2.19%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Fulgent Genetics share price in Dollar and Rupees. Guide to invest in Fulgent Genetics from India. Also see the sentimental analysis on Indian investors investing in Fulgent Genetics. Get details on the Indian mutual funds that are investing in Fulgent Genetics. Get Analyst recommendations and forecasts along with all the Fulgent Genetics's financials.

Fulgent Genetics share price movements

Today's Low: $18.33
Today's High: $19.15
$18.34
0.05%
Downside
Day's Volatility :4.28%
Upside
4.23%
52 Weeks Low: $16.56
52 Weeks High: $30.68
$18.34
9.71%
Downside
52 Weeks Volatility :46.02%
Upside
40.22%

Fulgent Genetics Returns

Period	Fulgent Genetics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-15.41%	-11.1%	0.0%
6 Months	-11.23%	-6.0%	0.0%
1 Year	-39.33%	2.7%	0.0%
3 Years	-82.39%	0.6%	-19.7%

Fulgent Genetics Key Statistics

in dollars & INR

Previous Close	$18.75
Open	$18.56
Today's High	$19.15
Today's Low	$18.33
Market Capitalization	$573.5M
Today's Volume	$625.3K
52 Week High	$30.68
52 Week Low	$16.56
Revenue TTM	$277.8M
EBITDA	$-60.8M
Earnings Per Share (EPS)	$-5.52
Profit Margin	-59.39%
Quarterly Earnings Growth YOY	-0.99%
Return On Equity TTM	-14.35%

How to invest in Fulgent Genetics from India?

It is very easy for Indian residents to invest directly in Fulgent Genetics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Fulgent Genetics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Fulgent Genetics or FLGT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Fulgent Genetics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Fulgent Genetics shares which would translate to 0.046 fractional shares of Fulgent Genetics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Fulgent Genetics, in just a few clicks!

Returns in Fulgent Genetics for Indian investors in Rupees

Investment Value

₹1,00,000

Fulgent Genetics investment value today

Current value as on today

₹1,41,528

Returns

₹41,528

(+41.53%)

Returns from Fulgent Genetics Stock

₹39,332 (false-39.33%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Fulgent Genetics

43%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Fulgent Genetics on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 43% more investors are searching Fulgent Genetics in the last 30 days versus the previous period.

Global Institutional Holdings in Fulgent Genetics

BlackRock Inc
12.82%
Vanguard Group Inc
4.74%
Millennium Management LLC
4.15%
Dimensional Fund Advisors, Inc.
3.62%
State Street Corp
2.59%
Park West Asset Management LLC
2.33%

Analyst Recommendation on Fulgent Genetics

Buy

66%Buy

33%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Fulgent Genetics(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Fulgent Genetics

What analysts predicted

Upside of 50.85%

Current:

$18.34

Target:

$27.67

Insights on Fulgent Genetics

Price Movement
In the last 1 month, FLGT stock has moved up by 8.2%
Increasing Revenue
Revenue is up for the last 3 quarters, 64.48M → 71.74M (in $), with an average increase of 5.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -8.71M → -14.64M (in $), with an average decrease of 68.2% per quarter
FLGT vs TMO (1 yr)
In the last 1 year, Fulgent Genetics Inc has experienced a drawdown of -38.5%, however Thermo Fisher Scientific, Inc. resisted the overall trend and outperformed by 38.0%
FLGT vs A (3 yr)
In the last 3 years, Fulgent Genetics Inc has experienced a drawdown of -82.1%, however Agilent Technologies Inc. resisted the overall trend and outperformed by 63.3%
Price to Sales
ForFLGT every $1 of sales, investors are willing to pay $2.0, whereas for Thermo Fisher Scientific, Inc., the investors are paying $4.7 for every $1 of sales.

Fulgent Genetics Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$21.4M	↑ 14.03%
Net Income	$-4.5M	↑ 68.7%
Net Profit Margin	-21.02%	↓ 6.81%

	FY19	Y/Y Change
Revenue	$32.5M	↑ 52.31%
Net Income	$366.0K	↓ 108.15%
Net Profit Margin	1.13%	↑ 22.15%

	FY20	Y/Y Change
Revenue	$421.7M	↑ 1196.46%
Net Income	$214.3M	↑ 58454.64%
Net Profit Margin	50.82%	↑ 49.69%

	FY21	Y/Y Change
Revenue	$992.6M	↑ 135.37%
Net Income	$104.3M	↓ 51.31%
Net Profit Margin	10.51%	↓ 40.31%

	FY22	Y/Y Change
Revenue	$619.0M	↓ 37.64%
Net Income	$143.4M	↑ 37.44%
Net Profit Margin	23.17%	↑ 12.66%

	FY23	Y/Y Change
Revenue	$289.2M	↓ 53.27%
Net Income	$-167.8M	↓ 217.03%
Net Profit Margin	-58.03%	↓ 81.2%

	Q2 FY23	Q/Q Change
Revenue	$67.9M	↑ 2.55%
Net Income	$-11.2M	↓ 29.15%
Net Profit Margin	-16.55%	↑ 7.4%

	Q3 FY23	Q/Q Change
Revenue	$84.7M	↑ 24.81%
Net Income	$-13.1M	↑ 16.72%
Net Profit Margin	-15.48%	↑ 1.07%

	Q4 FY23	Q/Q Change
Revenue	$70.5M	↓ 16.75%
Net Income	$-128.1M	↑ 877.71%
Net Profit Margin	-181.76%	↓ 166.28%

	Q1 FY24	Q/Q Change
Revenue	$64.5M	↓ 8.54%
Net Income	$-13.5M	↓ 89.5%
Net Profit Margin	-20.88%	↑ 160.88%

	Q2 FY24	Q/Q Change
Revenue	$71.0M	↑ 10.15%
Net Income	$-8.7M	↓ 35.3%
Net Profit Margin	-12.26%	↑ 8.62%

	Q3 FY24	Q/Q Change
Revenue	$71.7M	↑ 1.01%
Net Income	$-14.6M	↑ 68.17%
Net Profit Margin	-20.42%	↓ 8.16%

	FY18	Y/Y Change
Profit	$10.7M	↑ 4.77%

	FY19	Y/Y Change
Profit	$18.4M	↑ 72.72%

	FY20	Y/Y Change
Profit	$331.9M	↑ 1701.78%

	FY21	Y/Y Change
Profit	$777.1M	↑ 134.12%

	FY22	Y/Y Change
Profit	$366.9M	↓ 52.78%

	FY23	Y/Y Change
Profit	$104.5M	↓ 71.53%

	Q2 FY23	Q/Q Change
Profit	$20.6M	↑ 9.36%

	Q3 FY23	Q/Q Change
Profit	$39.8M	↑ 93.68%

	Q4 FY23	Q/Q Change
Profit	$23.3M	↓ 41.59%

	Q1 FY24	Q/Q Change
Profit	$20.1M	↓ 13.57%

	Q2 FY24	Q/Q Change
Profit	$24.5M	↑ 21.81%

	Q3 FY24	Q/Q Change
Profit	$26.8M	↑ 9.26%

	FY18	Y/Y Change
Operating Cash Flow	$-675.0K	↓ 150.71%
Investing Cash Flow	$950.0K	↓ 146.36%
Financing Cash Flow	$15.0K	↓ 101.95%

	FY19	Y/Y Change
Operating Cash Flow	$5.5M	↓ 917.33%
Investing Cash Flow	$-29.0M	↓ 3157.47%
Financing Cash Flow	$28.8M	↑ 191733.33%

	FY20	Y/Y Change
Operating Cash Flow	$140.6M	↑ 2448.99%
Investing Cash Flow	$-326.4M	↑ 1023.87%
Financing Cash Flow	$261.3M	↑ 807.91%

	FY21	Y/Y Change
Operating Cash Flow	$538.6M	↑ 282.98%
Investing Cash Flow	$-546.5M	↑ 67.43%
Financing Cash Flow	$85.4M	↓ 67.31%

	FY22	Y/Y Change
Operating Cash Flow	$253.5M	↓ 52.93%
Investing Cash Flow	$-261.3M	↓ 52.19%
Financing Cash Flow	$-77.1M	↓ 190.33%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$9.7M	↓ 223.14%
Investing Cash Flow	$-1.1M	↓ 74.83%
Financing Cash Flow	$-16.3M	↑ 1376.75%

Fulgent Genetics Technicals Summary

Sell

Neutral

Buy

Fulgent Genetics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Fulgent Genetics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Fulgent Genetics Inc	8.2%	-11.23%	-39.33%	-82.39%	23.17%
Idexx Laboratories, Inc.	-1.5%	-16.12%	-25.59%	-35.59%	56.17%
Agilent Technologies Inc.	1.86%	-0.42%	-3.63%	-14.2%	57.76%
Thermo Fisher Scientific, Inc.	1.54%	-7.4%	-0.95%	-19.59%	59.75%
Danaher Corp.	-2.77%	-10.99%	-0.79%	-28.51%	49.15%
Iqvia Holdings Inc.	-0.17%	-7.86%	-14.0%	-28.72%	27.38%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Fulgent Genetics Inc	7.49	NA	1.32	-0.16	-0.14	-0.04	NA	37.28
Idexx Laboratories, Inc.	39.52	39.52	4.31	10.73	0.59	0.23	NA	19.72
Agilent Technologies Inc.	30.02	30.02	2.26	5.24	0.25	0.08	0.01	20.53
Thermo Fisher Scientific, Inc.	32.35	32.35	1.97	21.7	0.13	0.05	0.0	128.08
Danaher Corp.	42.75	42.75	3.02	7.5	0.08	0.04	0.0	71.03
Iqvia Holdings Inc.	25.19	25.19	1.01	11.11	0.22	0.05	NA	38.37

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Fulgent Genetics Inc	Buy	$573.5M	23.17%	7.49	-59.39%
Idexx Laboratories, Inc.	Buy	$33.5B	56.17%	39.52	22.53%
Agilent Technologies Inc.	Buy	$38.4B	57.76%	30.02	21.75%
Thermo Fisher Scientific, Inc.	Buy	$197.6B	59.75%	32.35	14.48%
Danaher Corp.	Buy	$163.3B	49.15%	42.75	16.39%
Iqvia Holdings Inc.	Buy	$35.8B	27.38%	25.19	9.17%

About Fulgent Genetics

mission developing flexible and affordable genetic testing that improves the everyday lives of those around us. founded in 2011, fulgent began with two simple ideas; flexibility and affordability. today, we strive to create the most effective and wide ranging tests on the market. all of this is done in the pursuit of bettering the everyday lives of our customers. we shine brightest when meaningful relationships, passion, and purpose come together. why fulgent? we are committed to working side-by-side with every one of our clients. this is essential to a strong and successful relationship and is our core way of doing business. we have collaborated with some of the top clinicians in our field who have assisted us in creating our panels, report formatting, and improvements to our website. our approach has always been simple: provide testing based on the specific needs of clinicians and their patients. customer support our support philosophy has always been simple: answer our client's ques

Organization	Fulgent Genetics
Employees	1184
CEO	Mr. Ming Hsieh
Industry	Health Services

Management People of Fulgent Genetics

Name	Title
Mr. Ming Hsieh	Chairman & CEO
Mr. Jian Xie	COO & President
Mr. Paul Kim CPA	Chief Financial Officer
Dr. Hanlin Gao D.A.B.M.G., FACMG, M.D., Ph.D.	Chief Scientific Officer & Laboratory Director
Ms. Natalie Prescott	General Counsel & Chief Privacy Officer
Ms. Doreen Ng	VP of Operations & Compliance and GM of Houston Office
Mr. Jakub Sram	Vice President of Business Development & Sales
Ms. Ellen Tsui	Vice President of Human Resources
Mr. Brandon Perthuis	Chief Commercial Officer
Dr. Lawrence M. Weiss M.D.	Chief Medical Officer

Important FAQs about investing in Fulgent Genetics from India :

What is Fulgent Genetics share price today?

Fulgent Genetics share price today stands at $18.34, Open: $18.56 ; Previous Close: $18.75 ; High: $19.15 ; Low: $18.33 ; 52 Week High: $30.68 ; 52 Week Low: $16.56. The stock opens at $18.56, after a previous close of $18.75. The stock reached a daily high of $19.15 and a low of $18.33, with a 52-week high of $30.68 and a 52-week low of $16.56.

Can Indians buy Fulgent Genetics shares?

Yes, Indians can invest in the Fulgent Genetics (FLGT) from India.

With INDmoney, you can buy Fulgent Genetics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Fulgent Genetics at zero transaction cost.

How can I buy Fulgent Genetics shares from India?

It is very easy to buy Fulgent Genetics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Fulgent Genetics be purchased?

Yes, you can buy fractional shares of Fulgent Genetics with INDmoney app.

What are the documents required to start investing in Fulgent Genetics stocks?

To start investing in Fulgent Genetics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.